Lawdragon Names Four Seeger Weiss Partners to 500 Global Plaintiff Lawyers

Seeger Weiss is pleased to announce that Lawdragon has recognized four of the firm’s partners, including co-founders Chris Seeger and Stephen Weiss, as well as partners David Buchanan and Jennifer Scullion, on the 2024 Lawdragon 500 Global Plaintiff Lawyers. According to Lawdragon, this year’s honorees “stand tall as a global movement bringing justice across borders. […]

April 5, 2024

Seeger Weiss is pleased to announce that Lawdragon has recognized four of the firm’s partners, including co-founders Chris Seeger and Stephen Weiss, as well as partners David Buchanan and Jennifer Scullion, on the 2024 Lawdragon 500 Global Plaintiff Lawyers. According to Lawdragon, this year’s honorees “stand tall as a global movement bringing justice across borders. Its defining ethos is revolutionary – business and other interests now largely transcend jurisdiction, so should no longer be able to cabin responsibilities into outdated strictures.”

Chris Seeger, co-founding partner of Seeger Weiss, is widely recognized as a highly innovative and accomplished plaintiff attorney. He has led some of the most complex, groundbreaking, and high-profile litigations in the U.S, at both the state and federal level. He received more MDL appointments than any other lawyer between 2016 and 2019 and currently serves in leadership roles in MDLs including the 3M Combat Arms Earplug Litigation, National Prescription Opiate Litigation, Philips CPAP, Bi-Level PAP, and Mechanical Ventilator Litigation, and Social Media Adolescent Addiction/Personal Injury Litigation.

Stephen Weiss, co-founding partner of Seeger Weiss, chairs the firm’s qui tam/whistleblower practice, representing relators in some of the nation’s largest and most notable cases, including the recent $10 million settlement in a whistleblower lawsuit against medical device company Stimwave. His diverse practice spans high-profile multidistrict litigations, arbitrations, and private business disputes across various legal disciplines, including qui tam/whistleblower, consumer products, insurance, agricultural, environmental, securities, employment, and property rights litigation.

Senior partner Dave Buchanan represents individual and corporate plaintiffs in state and federal courts throughout the country. Most recently, Dave was appointed as co-lead counsel for the Self-Funded Payer Track in the In re: Insulin Pricing Litigation. Dave served as the co-chair of the Plaintiffs Steering Committee as well as head of the discovery committee in the 3M earplugs litigation, where he represented hundreds of thousands of men and women in uniform who suffered hearing loss, tinnitus, and loss of balance due to faulty earplugs, the largest mass tort in American history. He also served on the plaintiffs’ executive committee in the NFL Concussion Litigation and was co-chair of discovery as well as lead counsel in several bellwether trials in the Vioxx Litigation.

For over two decades, partner Jennifer Scullion has led complex litigations, arbitrations, and appeals for U.S. and multinational clients in a wide array of areas, including antitrust, consumer fraud, communications, civil rights, and international bondholder disputes. Her experience includes multidistrict litigations, class actions, and federal regulatory proceedings. Currently, Jen is a member of the Plaintiffs’ Executive Committee, Settlement Committee, Manufacturers’ Committee, and Law & Briefing Committee in the National Prescription Opiate Litigation, multidistrict litigation prosecuting RICO, public nuisance and related claims on behalf of local governments and co-lead counsel for negotiation class. She also continues to be a key member of the plaintiffs’ team leading efforts to hold social media companies accountable for products endangering the lives of children in the Social Media Harm litigation.

Lawdragon’s selection methodology is performed through independent journalistic research and submissions. Decisions are carefully made based on factors including research of top verdicts and settlements, peer recognition, and interviews with lawyers nationwide. The selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Related News

September 15, 2026
Lawdragon Names Seven Seeger Weiss Partners to 2027 500 Leading Litigators in America Guide

Lawdragon has recognized seven Seeger Weiss partners—Christopher Seeger, Stephen Weiss, Parvin Aminolroaya, Ben Barnett, David Buchanan, Shauna Itri, and Jennifer Scullion—in its 2027 Lawdragon 500 Leading Litigators in America guide. The guide highlights attorneys whose courtroom, investigative, and regulatory work has produced real impacts for the clients they represent, with many honorees credited with influencing entire […]

Read More
September 14, 2026
Seeger Weiss Recognized as a Finalist for Litigation Department of the Year, Products Liability/Mass Torts Category at the 2026 New Jersey Legal Awards

Seeger Weiss has been recognized as a finalist for Litigation Department of the Year, Products Liability/Mass Torts at the New Jersey Law Journal’s 2026 New Jersey Legal Awards. This recognition reflects a year of leadership appointments and firm growth across the department’s most significant matters. In March 2025, founding partner Christopher A. Seeger was appointed […]

Read More
September 2, 2026
Seeger Weiss Appointed as a Member of the Interim Plaintiffs’ Steering Committee in In re: Garden Grove Chemical Plant Evacuation Litigation

Seeger Weiss LLP has been appointed as a member of the Interim Plaintiffs’ Steering Committee in In re Garden Grove Chemical Plant Evacuation, a consolidated class action pending in the U.S. District Court for the Central District of California. Seeger Weiss founding partners Christopher A. Seeger and Stephen A. Weiss are leading the firm’s involvement […]

Read More